Cancel

NAVIGATING BIOSIMILARS: TRANSLATING EVIDENCE INTO CLINICAL PRACTICE

Leonard Calabrese, DO, and Steven Feldman, MD, PhD, provide their insights into the dynamic world of biosimilars, first highlighting key features of biologics and the rigorous scientific requirements for demonstrating biosimilarity.
Annenberg Center for Health Sciences at Eisenhower

New Oral Anticoagulants: Factor IIa and Xa Inhibitors

In this knowledge-based continuing pharmacy education activity Dr Michael Smith, RPh, PharmD, CACP discusses the new oral anticoagulation agents. Target Audience: Pharmacists who are interested in the management of patients on anticoagulation therapy and/or who are interested in starting pharmacy services for patients on anticoagulation therapy This activity is not accredited for technicians Learning objectives: At the conclusion of the activity, pharmacists will be able to: 1. ...
University of Connecticut School of Pharmacy

2015 - Neonatal Pharmacology

2015 - Neonatal Pharmacology Content Origination Date: May 14, 2015 ‐ Content Expiration Date: May 27, 2018 Total CE Credits: This online conference offers cutting edge information from some of the leading clinicians and researchers in neonatology. You will learn from these experts how to integrate best practices into your unit for a broad range of neonatal drugs, as well as managing care in the light of drug shortages. A faculty of experts in neonatal pharmacology who will challenge ...
Contemporary Forums

Neonatal Skin: Bacterial Colonization, Disinfection and Antimicrobial Bathing

Learning Objectives: Introduce the concept of the skin microbiome, and what is known about adults, children and neonatal skin microbiome. Discuss use of skin disinfectants in the NICU in terms of efficacy, toxicity and skin irritation. Review studies related to bathing the newborn with antimicrobial solutions and identify the pros and cons of this practice.
Contemporary Forums

Neonatal Abstinence Syndrome: Something Borrowed, Something New: Are There Best Therapies?

Learning Objectives: Demonstrate improved understanding of current limitations of pharmacologic management of neonatal abstinence syndrome. Have an improved knowledge base of current management options for treating neonatal abstinence. Articulate the ethical and moral challenges and dilemmas in caring for mothers and infants exposed to illicit substances.
Contemporary Forums

Vitamin A in the NICU: An Expensive Therapy for BPD Reduction. Is It Worth It?

Learning Objectives: Describe the mechanism used by Vitamin A to reduce the severity of BPD. Describe the clinical evidence supporting the use of vitamin to reduce BPD. Determine if the use of Vitamin A is cost effective and worthwhile in their NICU population.
Contemporary Forums

Neonatal Drug Formulations: Safety Gains and Risks

Learning Objectives: Describe the legal and regulatory challenges to pharmaceutical compounding for neonates. Describe clinical risks associated with pharmaceutical compounding for neonates. List compounded neonatal medications with recently published formulations.
Contemporary Forums

What's New in Neonatal Pharmacology and Drug Dosing?

Learning Objectives: Describe new dosing guidelines for at least 1 medication. Describe new safety information for at least 1 medication. Describe FDA final rule regarding drug labeling for use in pregnancy and lactation.
Contemporary Forums

Optimal Nutritional Management After Discharge in the Term and Preterm Neonate

Learning Objectives: List the limitations of our current nutritional discharge process. Identify the areas in nutrition that are important to consider for the growing preterm infant. Develop a framework that clearly creates a detailed nutritional discharge plan for your NICU.
Contemporary Forums

A Skeptic's View of Neonatal Medicine: Balancing Science and Art

Learning Objectives: Describe the indications for the use of bicarbonate in the NICU. Discuss the risks and benefits of postnatal steroids for BPD. Describe the limitations of probiotics for the prevention of NEC.
Contemporary Forums

Delivery Room Emergencies: Case Studies

Learning Objectives: Apply clinical assessment skills to the care of complex neonatal cases in delivery room. Discuss etiology, pathophysiology and management of selected neonatal cases. Describe emerging technologies and new therapies for these cases.
Contemporary Forums

Don't Forget the Kidneys! Renal Failure in the NICU Patient

Learning Objectives: Review key alterations in renal function compared to the adult. Develop an initial management plan for the infant with acute renal failure. Discuss potential long-term complications related to acute renal failure.
Contemporary Forums

Challenging Cases in Neonatal Ethics

Learning Objective: List the four basic principles of pediatric ethics. Discuss how pediatric ethics principles apply to newborns. Identify the challenges that arise when caregivers and parents disagree on the provision of care for critically ill newborns.
Contemporary Forums

Simulation in the Real World

Learning Objectives: List 5 major applications of healthcare simulation. Describe examples of improvements in outcomes from healthcare simulation. Review future directions & challenges in healthcare simulation
Contemporary Forums

Advances in Neonatal Medicine 2015

Learning Objectives: To know the limits of viability according to outcome data in 2015. To recognize the value of quality improvement in reducing mortality and morbidity. To be aware of the benefits of early nutrition and feeding human milk to preterm infants.
Contemporary Forums

Pharmacologic and Non-Pharmacologic Management of Neonatal Abstinence Syndrome

Learning Objectives: Describe the opioid epidemic in the United States Review the mechanisms of action of opiates and what causes withdrawal symptoms Describe current treatment strategies for NAS and outcomes
Contemporary Forums

Recognition and Management of Arrhythmias in the Fetus and Newborn

Learning Objectives: Recognize common fetal arrhythmias. Recognize common newborn arrhythmias. Recognize appropriate and inappropriate use of newborn EKGs.
Contemporary Forums

What's New for Antibiotics in the NICU?

Learning Objectives:​ Describe the goals of antimicrobial therapy. Describe how dosing is modified to achieve the goals of antimicrobial therapy. Describe dosing guidelines of medication used to treat infants with serious infections.
Contemporary Forums

The Synagis Debate: RSV Risk, Revised Recommendations, and Rising Cost

Learning Objectives: Discuss the prevalence of RSV and risk of hospitalization from severe disease across all neonatal and infant populations. Analyze data regarding palivizumab efficacy and cost effectiveness. Review revised 2014 palivizumab recommendations and discuss validity of changes.
Contemporary Forums

Current Neonatal Pain and Sedation Strategies: From Morphine to Dexmedetomidine

Learning Objectives: Discuss the effects of neonatal pain on brain development. Describe potential short- and long-term risks and benefits of morphine and dexmedetomidine in neonates. Providers will have increased knowledge on pain and sedation strategies in critically ill neonates.
Contemporary Forums

What is the Role for Steroids in Newborns with Cardiovascular Insufficiency?

Learning Objectives: Describe the basics of cortisol synthesis and physiology. Define relative adrenal insufficiency. Describe options for treatment of cardiovascular insufficiency.
Contemporary Forums

Veterinary Compounding Essentials

VETERINARY COMPOUNDING ESSENTIALS is a 15 hour practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing. Upon completion of this program, the participant will be able to: • Demonstrate knowledge of animal diseases where a compounding pharmacist ...
American College of Apothecaries

Redefining Care for BRCA and Other Familial-associated Cancers

Advances in molecular genetics and testing have refined the diagnosis, treatment, and follow-up for patients with BRCA and other familial genetic syndromes. As women with germline BRCA1 and BRCA2 mutations are at an increased risk for developing high-grade serous ovarian cancer, there are implications for genetic testing, family counseling, radiologic screening, and pharmaceutical choices in the community setting. Molecular and genetic advances, such as novel PARP inhibitors, are altering the ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Metastatic Breast Cancer

While mortality rates for breast cancer are decreasing, metastatic breast cancer (MBC) remains incurable. This session will review new treatment options based on molecular and genetic information, the level of evidence used to formulate practice guidelines, as well as updates from ASCO 2017. New agents, including PARP inhibitors for those with appropriate mutations, will also be discussed. Clinically-oriented guidelines on the management of MBC were developed by the European Society for Medica...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Achieving Precision Care in Gastrointestinal Cancers

Treatment selection is largely dependent on the goals of therapy; however, sequencing of standard therapies with newly approved therapies as patients’ progress is a key factor in improving quality of care. The recent approval of new agents and advances in biomarker detection have supported the individualization of treatment and subsequent improvements in survival for patients with gastrointestinal cancers. As new agents are expected to enter the treatment paradigm in 2017, clinicians will r...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

New Drugs and Drug News of 2017

Pharmacy practitioners need to be knowledgeable about new drugs introduced to the market, and public health advisories about drug therapy.
freeCE.com

ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development

The content of this overview course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program conducted within a drug development logic plan and in compliance with ICH guidelines. The various types of ADME, PK/TK, and DM studies, which include in vitro metabolism and delivery, animal and human pharmacokinetics, protein binding, mass balance, tissue distribution, metabolite isolati...
The Center for Professional Innovation and Education

Quality Assurance/Quality Control for Biologics and Biopharmaceuticals

In the eyes of regulatory authorities, the quality issues of biologics are definitely different from chemical drugs because of: (1) use of living source materials to produce the biologic, (2) increased complexity of biologic manufacturing processes and (3) increased complexity of the biologic molecules themselves. While chemical drugs can become generics, biologics products are best viewed as biosimilars, and not as bio-generics. Biologics are highly susceptible to adventitious agent contamin...
The Center for Professional Innovation and Education

Quality Assurance/Quality Control for Biologics and Biopharmaceuticals

In the eyes of regulatory authorities, the quality issues of biologics are definitely different from chemical drugs because of: (1) use of living source materials to produce the biologic, (2) increased complexity of biologic manufacturing processes and (3) increased complexity of the biologic molecules themselves. While chemical drugs can become generics, biologics products are best viewed as biosimilars, and not as bio-generics. Biologics are highly susceptible to adventitious agent contamin...
The Center for Professional Innovation and Education

Treatment Strategies in Chronic Leukemias and Introduction to CAR-T Therapy

Chronic lymphocytic (CLL) and chronic myelogenous (CML) leukemia are commonly diagnosed and treated by community oncologists. Whereas, in the past, these hematologic malignancies were considered incurable, new therapies have challenged that notion. Tyrosine kinase inhibitors (TKIs) annihilated the concept of CML as a poorly controlled disease, and most patients are now expected to live a normal life, with good quality of life. New testing procedures have suggested that some patients may be ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Payment Models and Practice Changes: Meeting Requirements of OCM & MACRA

Recent legislation and policy has fast-tracked the shift of healthcare payment from volume- to value-based reimbursement under the Medicare Access and CHIP Reauthorization Act (MACRA) for oncology care. Today, oncologists have the option to be reimbursed for Medicare patients under the CMS Oncology Care Model (OCM), an alternative payment model spanning a 6-month chemotherapy episode-of-care. This activity will provide insight into the program’s structure and challenges. It will also review ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Integrating Immunotherapy for NSCLC

The emergence of checkpoint inhibitors (CTLA4, PD1, PD-L1) has reawakened an interest in immunotherapy to treat various malignancies. New agents have rapidly been approved for use in melanoma, bladder cancer, renal cell, lung cancer, and other malignancies. These agents have a unique toxicity profile requiring careful clinical assessment, rapid intervention, and aggressive management of side effects. This activity will provide a general overview of immunotherapy in cancer treatment, with a ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, Rockpoointe Oncology

SEVERE ASTHMA: ENHANCING OUTCOMES THROUGH PHARMACIST INTERVENTION

Pharmacists are poised to expand their roles in asthma management, and there is much evidence indicating that doing so will improve outcomes, especially for patients with severe asthma. However, to do so pharmacists will need education regarding the current state of severe asthma management and emerging targeted biologic therapies. Pharmacists also need education on how to overcome barriers such as low patient confidence and interest in pharmacists as asthma management specialists, low pharmac...
American Academy of CME

12th Northeast Regional Hematology Oncology Pharmacists Symposium

Two day conference for pharmacists and nursing specializing in hematology/oncology. • 13 contact hours offered-2 law • Network with industry professionals • Enjoy breakfast, lunch, dinner & cocktail reception • Low fee to attend- including meals: Both days: Member-$140, Non members-$160 One day: Member-$110, Non member-$125
American Health Resources, LLC

Veterinary Compounding Essentials

VETERINARY COMPOUNDING ESSENTIALS is a 15 hour practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing. Upon completion of this program, the participant will be able to: • Demonstrate knowledge of animal diseases where a compounding pharmacist ...
American College of Apothecaries

Fundamental Compounding and Calculations

FUNDAMENTAL COMPOUNDING & CALCULATIONS is a 3-day, 21-hour practice-based course designed for pharmacists, technicians, marketers, and students who are new to compounding or who have had training in the past, but want a refresher. Physicians and other health care professionals are welcome to attend. This hands-on course focuses on the proper preparation of fundamental dosage forms utilized by pharmacies that are compounding medications for their patients. Participants will learn through...
American College of Apothecaries

Pre-Treatment Evaluation of the Patient with Hepatitis C Virus Infection

Learning Objectives As a result of participating in this activity, participants should be better able to: Discuss basic epidemiology of HCV in HIV infected populations Explain clinical and laboratory evaluation of HCV infection in preparation for antiviral therapy Counsel a patient with HCV/HIV about health maintenance Describe indication for liver cancer surveillance The content for this activity is drawn from the 11th Annual American Conference for the Treatment of HIV (ACTHI...
American Academy of CME and Beaumont Health

Chronic Pain in HIV Primary Care: A Practical, Evidence-Based Approach

Learning Objectives As a result of participating in this activity, participants should be better able to: Develop an evidence-based approach to the overall evaluation and management of chronic pain in people living with HIV Assess the risks and benefits of long-term opioid therapy in HIV-infected individuals with chronic pain (including risks in those who are not yet on opioids and those in whom opioid continuation is being assessed) The content for this activity is drawn from the 11...
American Academy of CME and Beaumont Health

The Opioid Epidemic and HIV: The Indiana HIV/HCV Outbreak: Implications for Prevention

Learning Objectives As a result of participating in this activity, participants should be better able to: Describe the key demographic changes in persons at risk for hepatitis C virus (HCV) and HIV infection in the United States Identify 3 risk factors associated with increased risk for vulnerability to new HCV or HIV infection among persons who inject drugs Identify 3 effective interventions to reduce the risk of HCV and HIV infections among persons who inject drugs The content f...
American Academy of CME and Beaumont Health

Rapid Entry and ART Initiation in HIV Care: Implementation of a New Paradigm

Learning Objectives As a result of participating in this activity, participants should be better able to: Describe the rationale and evidence for rapid entry into HIV Care Compare models of rapid entry from around the globe Identify challenges with implementation of rapid entry programs The content for this activity is drawn from the 11th Annual American Conference for the Treatment of HIV (ACTHIV 2018).
American Academy of CME and Beaumont Health

Is HIV Therapy Good Enough or Do We Still Need New Drugs?

Learning Objectives As a result of participating in this activity, participants should be better able to: Discuss the rationale for continued drug development in the era of well tolerated, single-tablet regimens Give examples of new agents in development and list their advantages over existing therapies List current regimens that could be initiated immediately, before baseline laboratory results are available Discuss the data supporting specific two-drug regimens The content for this...
American Academy of CME and Beaumont Health

Sexually Transmitted Infections (STIs): Management and Prevention Among HIV Positive Patients

Learning Objectives As a result of participating in this activity, participants should be better able to: Describe the current epidemiology of STI in persons with HIV infection Explain the clinical management and treatment recommendations for common STIs The content for this activity is drawn from the 11th Annual American Conference for the Treatment of HIV.
American Academy of CME and Beaumont Health

Hawaii CE/CME - Clinical Overview of New Advances in Lipid Management, Hypertension & Bone & Joint Diseases

Session 1: What’s New with Lipid Management: Managing Statin Intolerance, Consensus Recommendations, New Evidence, and PCSK9 Inhibitors Session 2: What’s New with Hypertension: How Low to Go, New Evidence, Consensus Recommendations, and Treating Resistant Hypertension Session 3: What’s New in Bone and Joint Disease: Focus on drug Therapy Management for Gout, Osteoarthritis, and Bioidentical Medications for Rheumatoid Arthritis
University Learning Systems

Live CE/CME Conference aboard Alaska Cruise

Day 1: Pharmacogenomics : Guided therapy in Psychiatry, Cardiology and Oncology (5 hrs) Day 2: Transcranial Magnetic Stimulation-A novel FDA approved non invasive and non pharmacological treatment for Major Depressive Disorder (2.5 hrs) Day 3: Designer Drugs and Opioids: Identification of Patients who present with manifestation, screening tools, and management. (2.5 hrs) Day 4:Pediatric Autism Spectrum: An Overview (2 hrs) Drug Shortages and its Impact on Patient Safety and Medica...
University Learning Systems

Las Vegas CE/CME - Therapeutic Update 2018

Session 1: New Drug Update Part 1 Session 2: New Drug Update part 2 Session 3: To be determined
University Learning Systems

FREE Patient Safety CME

Upgrade your practice of Patient Safety and earn FREE Patient Safety CME credits with Free Patient Safety CME programs from CMEList.com. Most programs are 1-2 hours long and feature slide-video lectures from specialists in Patient Safety.
CMEList.com

Handbook of Clinical Psychopharmacology for Therapists, 7th Ed

This is a test only course (book not included). The book (or e-book) can be purchased from Amazon or some other source. This CE test is based on the book "Handbook of Clinical Psychopharmacology for Therapists, 7th Ed." (2013, 369 pages), a highly readable text that has become the go-to resource for thousands of mental health clinicians seeking a reliable and easy-to-reference resource detailing the indications, contraindications, and side effects of psychopharmaceuticals. Organized by diso...
Professional Development Resources

Pharmacological Strategies for Trauma-Related Mental Health Complaints

Accumulation of findings implicating neurobiological dysregulations as well as overlapping features and frequent comorbidity with disorders that respond to pharmacotherapy have spurred interest in medication treatment for post-traumatic stress disorder (PTSD). While two medications from the selective serotonin reuptake inhibitor class have U.S. Food & Drug Administration approval for PTSD, there remains controversy regarding their overall efficacy and population specificity. Other classes of m...
International Society for Traumatic Stress Studies

Understanding Fibromyalgia

Understanding Fibromyalgia is an online nurisng CE course intended to help healthcare professionals recognize the symptoms of fibromyalgia and diagnose it early. It will discuss potential causes, signs and symptoms, criteria for diagnosis, and treatment options.
Corexcel

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.